 |
Publications from our COVID-19 Related Research Awardees |
We are proud to share nine outstanding publications from our research investigators, who have pioneered a new understanding of the genetic complexities of COVID-19 and its impact on the health of the general public. Among those publications, four have gained significant news media uptake, while three have been featured in high-impact journals in their respective fields. Read More
|
|
|
|
|
Professor, Speech, Language and Hearing Sciences,
Biomedical Engineering Otolaryngology Boston University
|
The BU CTSI congratulates Cara Stepp, Ph.D., on being promoted to Professor, Speech, Language and Hearing Sciences in Biomedical Engineering Otolaryngology. She is an outstanding researcher who was a recipient of a BU CTSI Covid-19 Related Research Award in 2020, and previously she was supported by the BU CTSI’s KL2 Career Development program. This early mentoring was key to Dr. Stepp's ability to fund her research program in speech science. Specifically, her work has been funded by the National Science Foundation (NSF) and the National Institutes of Health (NIH), with over $8M in research funds awarded. The goals of her work are to 1) improve the assessment and treatment of sensorimotor disorders of voice and speech and 2) contribute to the understanding of the relationships among neural control of movement, physiology, self-perception, acoustics, and listener auditory-perception of voice and speech. Read More
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries
Fogarty International Center (FIC)
|
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
National Institute on Drug Abuse (NIDA)
|
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
National Center for Advancing Translational Sciences (NCATS)
|
|
|
|
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy
|
Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy
National Institute of General Medical Sciences (NIGMS)
|
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
National Institute on Aging (NIA)
|
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19
Office of The Director, National Institutes of Health (OD)
|
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations
National Institute of Neurological Disorders and Stroke (NINDS)
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
|
|
|
|
Funding available: $22,500.00
LOIs are due May 1, 2021.
|
Boston MCRC will award one grant per year for a project period of 12 months. Pending the progress of the awarded pilot, the PI may submit a competitive renewal for the 2nd year of funding, which will be reviewed with all other applications. |
|
|
|
Funding: $600,000 for two years.
LOIs are due April 23, 2021.
|
The ADDF-Harrington Scholar Program is dedicated to accelerating the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias.
|
|
|
|
|
Application closes April 25, 2021.
|
As part of the Healthy Longevity Global Competition, the U.S. National Academy of Medicine (“NAM”), with support from Johnson & Johnson Innovation, will issue up to 24 Catalyst Awards per year, in three annual rounds (i.e., in 2020, 2021, and 2022). Each Catalyst Award includes a $50,000 cash prize as well as travel costs to attend an annual Innovator Summit.
|
|
|
|
|
Infections with ‘U.K Variant’ B.1.1.7 Have Greater Risk of Mortality
Since the genome sequence of SARS-CoV-2, was first reported in January 2020, thousands of variants have been reported, [which they] haven't raised any alarm among public health officials. But that’s now changed with the emergence of at least three variants carrying mutations. Read More
|
|
|
|
|
Scientists Find Evidence that Novel Coronavirus Infects the Mouth’s Cells
Researchers already know that the saliva of people with COVID-19 can contain high levels of SARS-CoV-2, and studies suggest that saliva testing is nearly as reliable as deep nasal swabbing for diagnosing COVID-19.
|
|
|
|
|
RADx Diversifies COVID-19 Test Portfolio with Four New Contracts, Including One to Detect Variants
The four new contracts, administered by NIH’s Rapid Acceleration of Diagnostics Tech (RADx) initiative, total $29.3 million and will help increase testing capacity at the point-of-care and in labs for COVID-19 surveillance in schools, businesses, and communities. Read More
|
|
|
|
|
Pfizer Launches COVID-19 Vaccine Test in Children as New Data Support mRNA Shots in Pregnant Women
While COVID-19 shots have proven effective in clinical trials—and now in the real world, too—relatively little is known about how they work in children and pregnant women. Moderna, Pfizer, and Johnson & Johnson aim to change that.
|
|
|
|
|
Upcoming Courses & Events |
|
|
|
|
Part 1: Data, Race, and COVID-19
Apr. 5, 2021, 4:30 - 6 p.m.
|
This three-part series will examine the racial disparities in health brought vividly to public attention during the COVID-19 pandemic. The first panel in our series will explore the importance of collecting and utilizing data on race to better understand the impact of the pandemic. More Details Here
|
|
|
|
|
The Russell Sage Foundation, in partnership with the Office of Research and Foundation Relations, will present a workshop to help acquaint social scientists at BU with the Foundation’s mission, funding priorities, programs, and grant application protocols. More Details Here
|
|
|
|
|
Cognitive Reserve, Resilience, & Resistance Symposium
Apr. 9, 2021, 1 - 4 p.m.
|
Co-Hosted by the Precision Medicine for Alzheimer Disease and Related Disorders and the BU Alzheimer's Disease Center
Sponsored by the BU Alzheimer's Disease Center, American Heart Association, Framingham Heart Study Brain Aging Program, and the Evans Center for Interdisciplinary Biomedical Research
Renowned experts will be presenting an overview of their work on cognitive reserve, resilience, and resistance. Highlights include research on factors and underlying mechanisms that may determine an individual ability to avoid cognitive impairment. These presentations will help to shed more light on how some are able to remain cognitively healthy through aging and to identify effective dementia prevention strategies. Register here
|
Covid-19 and Thrombosis Complications Virtual Mini-Symposium
May 10, 2021, 12 – 2 p.m.
Thrombosis and Hemostasis in Health and Disease ARC & the Whitaker Cardiovascular Institute Boston University School of Medicine. More Details Here
|
Join via Zoom here. Meeting ID: 974 8781 0263 // Passcode: 343319
|
|
|
|
|
Symposium
Apr. 14, 2021, 9 a.m. – 3:30 p.m.
Speakers from Harvard T.H. Chan School of Public Health, Harvard Medical School, Dana-Farber Cancer Institute, Pfizer, and other experts present on precision medicine at our annual biostatistics symposium. More Details Here
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
|
|
|
|
|
|
